Medicago and GSK’s plant based Covid-19 vaccine candidate show promise in Phase 3 trials
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.
Carestream equipment is highly recommended for its imaging quality
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Acute therapies continue to report strong growth compared to chronic ones.
The MoU was signed on World Organ Donation Day which falls on August 13
Subscribe To Our Newsletter & Stay Updated